BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 24928558)

  • 1. Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation.
    Bayman E; Prestwich RJ; Speight R; Aspin L; Garratt L; Wilson S; Dyker KE; Sen M
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):636-42. PubMed ID: 24928558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and topographic characterization of locoregional recurrences in head and neck tumours.
    Ferreira BC; Marques RV; Khouri L; Santos T; Sá-Couto P; do Carmo Lopes M
    Radiat Oncol; 2015 Feb; 10():41. PubMed ID: 25889988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma.
    Loo SW; Geropantas K; Wilson P; Martin WM; Roques TW
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):162-70. PubMed ID: 22906546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial.
    Shakam A; Scrimger R; Liu D; Mohamed M; Parliament M; Field GC; El-Gayed A; Cadman P; Jha N; Warkentin H; Skarsgard D; Zhu Q; Ghosh S
    Radiother Oncol; 2011 May; 99(2):101-7. PubMed ID: 21621868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
    Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional recurrences after post-operative volumetric modulated arc radiotherapy (VMAT) in oral cavity cancers in a resource constrained setting: experience and lessons learned.
    Chakraborty S; Patil VM; Babu S; Muttath G; Thiagarajan SK
    Br J Radiol; 2015 Apr; 88(1048):20140795. PubMed ID: 25645107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?
    Chen AM; Farwell DG; Luu Q; Donald PJ; Perks J; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):943-9. PubMed ID: 20932680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
    Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; Cho BC; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ
    Oral Oncol; 2013 Mar; 49(3):255-60. PubMed ID: 23079695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
    Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer.
    Schoenfeld GO; Amdur RJ; Morris CG; Li JG; Hinerman RW; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):377-85. PubMed ID: 18164838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer.
    Johansen S; Norman MH; Dale E; Amdal CD; Furre T; Malinen E; Evensen JF
    Radiat Oncol; 2017 May; 12(1):87. PubMed ID: 28545588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
    Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma.
    Raktoe SA; Dehnad H; Raaijmakers CP; Braunius W; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):136-41. PubMed ID: 22541959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.